Act 315 Enacts R.S. 17:436.1(N) to require the governing authority of each public elementary and secondary school to adopt a policy to maintain a supply of auto-injectable Epinephrine in a secure location in each classroom assigned to a student who is deemed by his physician to be at high risk for anaphylactic reaction and incapable of self-administration of auto-injectable Epinephrine. Such policy shall require the student’s parent or legal guardian to annually provide the school with the supply of Epinephrine, written certification from the student’s licensed medical physician that the student is at high risk of having anaphylaxis, written authorization for the student to be administered the medication, and a treatment plan from the student’s licensed medical physician for managing anaphylactic episodes. The governing authority of the public elementary and secondary school shall inform the parent or legal guardian of the student in writing that the school and its employees shall incur no liability as a result of any injuries sustained by the student from the good faith administration of auto-injectable Epinephrine. The parent or legal guardian shall sign a statement acknowledging that the school shall incur no liability and that the parent or legal guardian shall indemnify and hold harmless the school and its employees against any claims that may arise relating to the good faith administration of auto-injectable Epinephrine. Each school shall include the policy required by this statute in its student handbook and shall post it on the school’s website if it has one. [Effective 6/10/22].